Women's healthcare faces an uphill battle after centuries of being ignored. Yet, ironically enough, women currently share half of the consumerism market, hold power over 80% of household financial decisions, and make 70% of healthcare-related choices in their families. Despite this, their access to proper healthcare often comes up short. But with the market for women's healthcare predicted to be worth over $47 billion, changes are starting to occur. And with the recent attacks and laws on
Read More
Breast Cancer
Biden Admin Builds on Cancer Moonshot with 13 More Initiatives
What You Should Know: - One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today. - The Cancer Moonshot has spurred tremendous action across the federal government and from the public and private
Read More
Praying For The Survival of the NHS Will Not Be Enough To Save It
It’s often said that the National Health Service is the closest thing Britain has to a unifying religion. If that is the case, then the faith of the population is being tested like never before, With budgets already stretched before the COVID pandemic, additional cost pressures since heaped on health boards across the country by double-digit inflation have brought the NHS closer to breaking point than at any time in its history. Every passing day seems to bring bleaker news for the
Read More
Medical Natural Language Processing Tech Has Come of Age
For many years, natural language processing (NLP) has held the promise of dramatically increasing the ability of healthcare organizations to quickly and accurately understand unstructured medical text in clinical notes. Using medical NLP, healthcare providers, clinical researchers, and payers would uncover meaningful insights hidden in unstructured text faster, with fewer errors, and at less cost than manual data review and analysis. This high-quality medical-grade data in turn would drive
Read More
Ibex Study Finds AI Highly Accurate in Cancer Identification
What You Should Know: - The latest study from Ibex Medical Analytics and the Institut Curie, published in Nature, demonstrates how AI implementation across pathology labs can significantly improve the outcome of cancer care. - The study analyzed Ibex’s AI-based quality control solution for breast biopsy review on over 15,000 slides over a diverse cohort. The study found the AI algorithm achieved high accuracy in identifying various types of cancer and 51 different morphological features of
Read More
New Liquid Biopsy Detects Breast Cancer at Its Earliest Stages
What You Should Know: - Exai Bio and researchers at UCSF released data demonstrating that Exai’s novel, RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages and smallest tumor sizes. - Earlier detection of breast cancer is crucial for optimal patient outcomes but cannot always be achieved based on symptoms or mammography. Non-Invasive Blood-Based Platform Delivers Promising Data on Detecting Breast Cancer At It’s Earliest Stages Exai Bio is a
Read More
RNSA22: NVIDIA Partners With NHS Trusts to Deploy AI Platform in UK Hospitals
What You Should Know: - A consortium of 10 National Health Service Trusts — the publicly funded healthcare system in England — is now deploying the MONAI-based AIDE platform across four of its hospitals, providing artificial intelligence (AI)-enabled disease-detection tools to healthcare professionals serving 5 million patients a year. - AIDE, short for AI Deployment Engine, is expected to be rolled out next year across 11 NHS hospitals serving 18 million patients, bringing AI
Read More
Oatmeal Health Brings AI-Powered Lung Cancer Screening to The Clinic in Oklahoma
What You Should Know: - Central Oklahoma Family Medical Center FQHC (The Clinic) has selected Oatmeal Health, a veteran-owned Patient Success Service to bring tech-enabled lung cancer screenings to their patients. - As part of the partnership, Oatmeal Health will provide white-glove, concierge service, offering our support without FQHC’s shouldering the burden or cost. Tech-Enabled Lung Cancer Screening Currently, lung screening rates hover at around 4 percent
Read More
Research: Proscia AI Predicts Diagnostic Agreement for Melanoma
What You Should Know: - Proscia® a provider of digital and computational pathology solutions, has released study results on new artificial intelligence (AI) that predicts diagnostic agreement for melanoma, the deadliest form of skin cancer. - The findings, which were presented at the European Conference on Computer Vision (ECCV) 2022, highlight the potential of the technology to improve diagnostic accuracy for melanoma and other diseases with low pathologist concordance. Findings
Read More
How Actionable Data and Expert Analysis Supports Service Providers, Fosters Better Care and Ensures Financial Benefits
Approximately 42% of Medicare beneficiaries are enrolled in Medicare Advantage plans—a segment projected to reach 46% by 2025. Due to rapid growth of the 65-and-older portion of the population, Medicare expenditures are forecast to reach $1,559.4 billion in 2028, with spending per enrollee reaching $20,751. Key trends are influencing this growth, including: - An aging population - Continued increase in overall Medicare costs - Government support and benefit flexibility (e.g.,
Read More